Tsing Song Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
85
- Portfolio
-
52
- Exits
-
13
Tsing Song Capital General Information
Company Description
Founded in 2017, Tsing Song Capital is a venture capital firm based in Beijing, China. The firm focuses on making investments in the healthcare and life science sector startups.
Business Details
Website
www.ctsfunds.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Suite 405,Tower B,Grand Pacific Trade Centre
- 8A Guanghua Road,Chaoyang District
- Beijing, 100026
- China
Tsing Song Capital Investments (85)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| PERTURBMIND | 26-Oct-2026 | Early Stage VC | Discovery Tools (Healthcare) | Generating Revenue | ||
| Gestala (Diagnostic Equipment) | 02-Jul-2026 | Diagnostic Equipment | Generating Revenue | |||
| Xellar Biosystems | 29-Jun-2026 | Discovery Tools (Healthcare) | Generating Revenue | |||
| TINGSN | 10-Jun-2026 | Surgical Devices | Generating Revenue | |||
| ChainGen Bio | 02-Jun-2026 | Drug Delivery | Generating Revenue | |||
| Rushen Robot | 30-Apr-2026 | Computers, Parts and Peripherals | Generating Revenue | |||
| Caibo Medical | 29-Apr-2026 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Gestala (Diagnostic Equipment) | 12-Mar-2026 | Diagnostic Equipment | Generating Revenue | |||
| TINGSN | 03-Mar-2026 | Later Stage VC | Surgical Devices | Generating Revenue | ||
| CoreRhythm Medical Technology | 24-Feb-2026 | Later Stage VC | Monitoring Equipment | Generating Revenue |
Tsing Song Capital Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Oculgen | 22-Dec-2025 | Secondary Transaction - Private | |
| LaNova Medicines | 20-Aug-2025 | ||
| Weixu Biotechnology | 25-Dec-2024 | ||
| HaoDF | 14-Sep-2024 | ||
| Giant Biogene | 03-Nov-2022 | ||
| United-Imaging | 22-Aug-2022 | ||
| RecBio | 30-Mar-2022 | ||
| Kesairui Bio | 13-Jan-2022 | ||
| Sino Biological | 16-Aug-2021 | IPO | |
| SinocellTech | 22-Jun-2020 | IPO |
Tsing Song Capital Investments by Industry, Year, and Region
Tsing Song Capital Co-Investors (131)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| HSG (Hong Kong) | 4 |
|
|
||
| Blue Lake Capital |
|
|
|||
| Qiming Venture Partners |
|
|
|||
| YuanBio Venture Capital |
|
|
|||
| Suzhou Oriza Holdings Corporation |
|
|
Tsing Song Capital FAQs
-
What is Tsing Song Capital?
Founded in 2017, Tsing Song Capital is a venture capital firm based in Beijing, China.
-
When was Tsing Song Capital founded?
Tsing Song Capital was founded in 2017.
-
Where is Tsing Song Capital headquartered?
Tsing Song Capital is headquartered in Beijing, China.
-
How many investments has Tsing Song Capital made?
Tsing Song Capital has made 85 investments.
-
What has Tsing Song Capital invested in?
Tsing Song Capital has made numerous investments in companies like PERTURBMIND, Gestala (Diagnostic Equipment), and Xellar Biosystems within the Discovery Tools (Healthcare) and Diagnostic Equipment industries.
-
What has Tsing Song Capital invested in recently?
Tsing Song Capital's latest investment was on 26-Oct-2026 in PERTURBMIND, a company within the Discovery Tools (Healthcare) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process